Financings
Nanalysis increases placement, closes first tranche

NSCI · Price
Executive Summary
- Nanalysis Scientific Corp. has closed the first tranche of its non-brokered private placement, raising approximately $2.5 million, and announced an upsize to the total offering size due to strong investor demand.
- The company plans to close the second tranche in January 2026, with total gross proceeds potentially reaching $6.0 million (combined first and second tranches) to be used for debt reduction and inventory purchases.
- The offering includes warrants with a 20-cent exercise price and a specific acceleration clause tied to share price performance on the TSX Venture Exchange.
Key Details
- First Tranche Closing:
- Units issued: 16,526,283 units.
- Price per unit: $0.15.
- Gross proceeds: Approximately $2.5 million.
- Use of proceeds: Debt reduction.
- Finder's fee paid: $1,500 cash to Haywood Securities Inc.
- Regulatory status: Subject to final acceptance of the TSX Venture Exchange.
- Hold period: Four months and one day from issuance.
- Offering Upsize:
- Additional units: Up to 23,333,333 units.
- Price per unit: $0.15.
- Additional gross proceeds: Up to $3.5 million.
- Total potential gross proceeds: Up to $6.0 million.
- Use of proceeds: Debt reduction and magnet inventory purchases.
- Regulatory status: Subject to approval of the TSX Venture Exchange.
- Warrant Terms:
- Structure: Each unit consists of one common share and one-half of one common share purchase warrant.
- Exercise Price: $0.20 per share.
- Expiry: Two years from the applicable closing date.
- Acceleration Provision: If the share closing price on the TSX Venture Exchange equals or exceeds $0.30 for any 10 consecutive trading days, the company may accelerate the warrant expiry to 30 days after notice/press release.
- Insider Participation:
- Insider: Sean Krakiwsky.
- Subscription amount: $52,500.
- Units subscribed: 350,000 units.
- Transaction type: Related-party transaction under Multilateral Instrument 61-101.
- Exemptions relied upon: Sections 5.5(a) and 5.7(1)(a) of MI 61-101 (fair market value does not exceed 25% of market capitalization).
- Finder's Fees:
- Potential fee: Up to 5% on parts of proceeds for purchasers introduced by registered investment advisers, payable in cash.
More from Nanalysis Scientific Corp
Jun 23, 2026 · 17:00